Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Brachytherapy × Gynecologic × Clear all

Phase

Status

Sponsor Class

OTHER 47 NIH 16 NETWORK 15 INDUSTRY 7 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Cisplatin 6 apatinib 5 Surgical Procedures, Operative 4 Paclitaxel 4 Hydralazine 4 Gemcitabine 4 Carboplatin 4 Valproic Acid 3 Radiotherapy 3 Neoadjuvant Therapy 3 Hyperthermic Intraperitoneal Chemotherapy 3 Drug Therapy 3 Bevacizumab 3 taxane 2 pembrolizumab 2 cetrorelix 2 Radiotherapy, Intensity-Modulated 2 Probiotics 2 Poly(ADP-ribose) Polymerase Inhibitors 2 Metformin 2 Laparoscopy 2 Curcumin 2 CP protocol 2 spartalizumab 1 piperine 1 olaparib 1 niraparib 1 nimotuzumab 1 lenvatinib 1 fluzoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02957266 2016-11-15

CERVIPIB

The National Center of Oncology, Azerbaijan

Phase 3 Unknown

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡